Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 70, Issue 3, 2015, Pages 310-318

  Guo, M M H ^a,b   Tseng, W N ^a,b   Ko, C H ^a   Pan, H M ^a,b   Hsieh, K S ^a,b   Kuo, H C ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

cytokines; intravenous immunoglobulin resistance; Kawasaki disease; regulatory T cells; T helper 17 cells

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; MESSENGER RNA; RETINOIC ACID RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN;

ARTICLE; BLOOD SAMPLING; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; BLOOD; CD4 LYMPHOCYTE COUNT; COMPLICATION; CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INFANT; METABOLISM;

CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOPHENOTYPING; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84922224990     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12558     Document Type: Article

References (35)

1. Burns JC, Glode MP,. Kawasaki syndrome. Lancet 2004; 364: 533-544.
2. Burns JC, Shike H, Gordon JB, Malhotra A, Schoenwetter M, Kawasaki T,. Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 1996; 28: 253-257.
3. Oates-Whitehead RM, Baumer JH, Haines L, Love S, Maconochie IK, Gupta A, et al. Intravenous immunoglobulin for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev 2003;CD004000.
4. Huang WC, Huang LM, Chang IS, Chang LY, Chiang BL, Chen PJ, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123: e401-e405.
5. Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB,. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J 2010; 29: 483-488.
6. Uehara R, Yashiro M, Nakamura Y, Yanagawa H,. Parents with a history of Kawasaki disease whose child also had the same disease. Pediatr Int 2011; 53: 511-514.
7. Uehara R, Yashiro M, Nakamura Y, Yanagawa H,. Kawasaki disease in parents and children. Acta Paediatr 2003; 92: 694-697.
8. Takahashi K, Oharaseki T, Yokouchi Y,. Update on etio and immunopathogenesis of Kawasaki disease. Curr Opin Rheumatol 2014; 26: 31-36.
9. Afzali B, Lombardi G, Lechler RI, Lord GM,. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46.
10. Kuo HC, Yang KD, Juo SH, Liang CD, Chen WC, Wang YS, et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS ONE 2011; 6: e17370.
11. Kuo HC, Wang CL, Liang CD, Yu HR, Huang CF, Wang L, et al. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol 2009; 20: 266-272.
12. Huang Y, Shan J, Zhang C, Zhang J, Feng L, Li S, et al. Peripheral blood T regulatory cell counts may not predict transplant rejection. BMC Immunol 2010; 11: 40.
13. Baratelli F, Lin Y, Zhu L, Yang SC, Heuze-Vourc'h N, Zeng G, et al. Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells. J Immunol 2005; 175: 1483-1490.
14. Manel N, Unutmaz D, Littman DR,. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641-649.
15. Yeung RS,. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol 2010; 22: 551-560.
16. Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 2012; 44: 522-525.
17. Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, Huang YH, et al. Polymorphisms of transforming growth factor-beta signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet 2011; 56: 840-845.
18. Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40: 35-42.
19. Sohn MH, Noh SY, Chang W, Shin KM, Kim DS,. Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol 2003; 32: 364-366.
20. Jia S, Li C, Wang G, Yang J, Zu Y,. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol 2010; 162: 131-137.
21. Kirkham BW, Kavanaugh A, Reich K,. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis. Immunology 2014; 141: 133-142.
22. Ohsugi Y,. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull 2007; 30: 2001-2006.
23. Olivito B, Taddio A, Simonini G, Massai C, Ciullini S, Gambineri E, et al. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin Exp Rheumatol 2010; 28 (1 Suppl 57): 93-97.
24. Sohn SY, Song YW, Yeo YK, Kim YK, Jang GY, Woo CW, et al. Alteration of CD4CD25Foxp3 T cell level in Kawasaki disease. Korean J Pediatr 2011; 54: 157-162.
25. Furuno K, Yuge T, Kusuhara K, Takada H, Nishio H, Khajoee V, et al. CD25+CD4+ regulatory T cells in patients with Kawasaki disease. J Pediatr 2004; 145: 385-390.
26. Kimura J, Takada H, Nomura A, Ohno T, Mizuno Y, Saito M, et al. Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease. Clin Exp Immunol 2004; 137: 444-449.
27. Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S,. Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease. Scand J Rheumatol 1997; 26: 314-317.
28. Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Arthritis Rheum 2013; 65: 805-814.
29. Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L, Huang SC, et al. Augmented TLR2 expression on monocytes in both human Kawasaki disease and a mouse model of coronary arteritis. PLoS ONE 2012; 7: e38635.
30. Kobayashi N, Mori M, Kobayashi Y, Miyamae T, Imagawa T, Okuyama T, et al. Intravenous gamma-globulin therapy improves hypercytokinemia in the acute phase of Kawasaki disease. Mod Rheumatol 2004; 14: 447-452.
31. Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, et al. Immunomodulation by intravenous immunoglobulin: role of regulatory T cells. J Clin Immunol 2010; 30 (Suppl 1): S4-S8.
32. Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J 2008; 27: 155-160.
33. Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP,. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998; 17: 1144-1148.
34. Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 2009; 124: 1-8.
35. Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, et al. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med 2006; 160: 686-690.